Role of neutrophil elastase in development of pulmonary vascular injury and septic shock in rats

Shock

Volumn 30, Issue 4, 2008, Pages 379-387

  Harada, Naoaki ^a   Okajima, Kenji ^a   Isobe, Hirotaka ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Acute respiratory distress syndrome; NO; Prostacyclin; Septic shock; TNF

Indexed keywords

3 ACETOXYMETHYL 2 (2 CARBOXY 1 PYRROLIDINYLCARBONYL) 7ALPHA METHOXY 8 OXO 5 THIA 1 AZABICYCLO[4.2.0]OCT 2 ENE 5,5 DIOXIDE; 6 OXOPROSTAGLANDIN F1 ALPHA; ARGININE; ENDOTOXIN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LEUKOCYTE ELASTASE; PROSTACYCLIN; SIVELESTAT; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; HYPOTENSION; LUNG INJURY; LUNG PARENCHYMA; NONHUMAN; PROTEIN EXPRESSION; RAT; SEPTIC SHOCK;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; CEPHALOSPORINS; ENDOTOXINS; ENZYME INHIBITORS; LEUKOCYTE ELASTASE; LUNG; LUNG DISEASES; MALE; NITRIC OXIDE; RATS; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR DISEASES;

EID: 40949103148     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181673e2c     Document Type: Article

References (50)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992.
2. St John RC, Dorinsky PM: Immunologic therapy for ARDS. septic shock, and multiple-organ failure. Chest 103:932-943, 1993.
3. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477, 1993.
4. Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM, Waltersdorph AM: Stimulation of neutrophils by tumor necrosis factor. J Immunol 136:4220-4225, 1986.
5. Thiemermann C, Wu CC, Szabo C, Perretti M, Vane JR: Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br J Pharmacol 110:177-182, 1993.
6. Thiemermann C, Vane J: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182:591-595, 1990.
7. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
8. Szabo C, Mitchell JA, Thiemermann C, Vane JR: Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 108:786-792, 1993.
9. Lee RP, Wang D, Kao SJ, Chen HI: The lung is the major site that produces nitric oxide to induce acute pulmonary oedema in endotoxin shock. Clin Exp Pharmacol Physiol 28:315-320, 2001.
10. Enkhbaatar P, Okajima K, Murakami K, Uchiba M, Okabe H, Okabe K, Yamaguchi Y: Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation. Am J Respir Crit Care Med 162:1752-1759, 2000.
11. 2) in chloralose anaesthetized dogs [proceedings]. Br J Pharmacol 61:136P, 1977.
12. Eisenhut T, Sinha B, Grottrup-Wolfers E, Semmler J, Siess W, Endres S: Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cells. Immunopharmaeology 26:259-264, 1993.
13. Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K: Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III. Am J Physiol 270:L921-L930, 1996.
14. Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K: Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 272:L197-L202, 1997.
15. Isobe H, Okajima K, Uchiba M, Harada N, Okabe H: Antithrombin prevents endotoxin-induced hypotension by inhibiting the induction of nitric oxide synthase in rats. Blood 99:1638-1645, 2002.
16. Gryglewski RJ, Korhut R, Ocetkiewicz A: Generation of prostacyclin by lungs in vivo and its release into the arterial circulation. Nature 273:765-767, 1978.
17. Gryglewski RJ, Korbut R, Ocetkiewicz A, Splawinski J, Wojtaszek B, Swies J: Lungs as a generator of prostacyclin - hypothesis on physiological significance. Naunyn Schmiedebergs Arch Pharmacol 304:45-50, 1978.
18. Gust R, Kozlowski J, Stephenson AH, Schuster DP: Synergistic hemodynamic effects of low-dose endotoxin and acute lung injury. Am J Respir Crit Care Med 157:1919-1926, 1998.
19. Harada N, Okajima K, Uchiba M, Katsuragi T: Contribution of capsaicin-sensitive sensory neurons to stress-induced increases in gastric tissue levels of prostaglandins in rats. Am J Physiol Gastrointest Liver Phvsiol 285:G1214-G1224, 2003.
20. Okajima K, Harada N, Uchiba M, Mori M: Neutrophil elastase contributes to the development of ischemia-reperfusion-induced liver injury by decreasing endothelial production of prostacyclin in rats. Am J Physiol Gastrointest Liver Physiol 287:G1116-G1123, 2004.
21. Hisanaga Y, Goto H, Tachi K, Hayakawa T, Sugiyama S: Implication of nitric oxide synthase activity in the genesis of water immersion stress-induced gastric lesions in rats: the protective effects of FK506. Aliment Pharmacol Ther 10:933-940, 1996.
22. Kawabata K, Suzuki M, Sugitani M, Imaki K, Toda M, Miyamolo T: ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun 177:814-820, 1991.
23. Leung D, Abbenante G, Fairlie DP: Protease inhibitors: current status and future prospects. J Med Chem 43:305-341, 2000.
24. Keller GA, West MA, Cerra FB, Simmons RL: Macrophage-mediated modulation of hepatic function in multiple-system failure. J Surg Res 39:555-563, 1985.
25. G- nitroarginine. Biochemistry 32:8512-8517, 1993.
26. Avontuur JA, Buijk SL, Bruining HA: Distribution and metabolism of N(G)-nitro-L-arginine methyl ester in patients with septic shock. Eur J Clin Pharmacol 54:627-631, 1998.
27. Gierse JK, Koboldt CM, Walker MC, Seibert K, Isakson PC: Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J 339(Pt 3):607-614, 1999.
28. Hvidberg E, Lausen HH, Jansen JA: Indomethacin: plasma concentrations and protein binding in man. Eur J Clin Pharmacol 4:119-124, 1972.
29. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG: 1400W is a slow, tight binding, and highly selective inhibitor of inducible nilric-oxide synthase in vitro and in vivo. J Biol Chem 272:4959-4963, 1997.
30. Molor-Erdene P, Okajima K, Isobe H, Uchiba M, Harada N, Okabe H: Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression. Am J Physiol 288:H1265-H1271, 2005.
31. Harada N, Okajima K, Yuksel M, Isobe H: Contribution of capsaicin-sensitive sensory neurons to antithrombin-induced reduction of ischemia/reperfusion-induced liver injury in rats. Thromb Haemost 93:48-56, 2005.
32. Chang SW: Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor. J Lab Clin Med 123:65-72, 1994.
33. 15N]nitrate in biological fluids. Anal Biochem 126:131-138, 1982.
34. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
35. Isobe H, Okajima K, Uchiba M, Mizutani A, Harada N, Nagasaki A, Okabe K: Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 104:1171-1175, 2001.
36. LeRoy EC, Ager A, Gordon JL: Effects of neutrophil elastase and other proteases on porcine aortic endothelial prostaglandin 12 production, adenine nucleotide release, and responses to vasoactive agents. J Clin Invest 74:1003-1010, 1984.
37. Weksler BB, Jaffe EA, Brower MS, Cole OF: Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells. Blood 74:1627-1634, 1989.
38. Renesto P, Si-Tahar M, Moniatte M, Balloy V, Van Dorsselaer A, Pidard D, Chignard M: Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor. Blood 89:1944-1953, 1997.
39. Jorres A, Dimer H, Topley N, Gahl GM, Frei U, Scholz P: Inhibition of tumour necrosis factor production in endotoxin-stimulated human mononuclear leukocytes by the prostacyclin analogue iloprost: cellular mechanisms. Cytokine 9:119-125, 1997.
40. Okajima K, Isobe H, Uchiba M, Harada N: Role of sensory neuron in reduction of endotoxin-induced hypotension in rats. Crit Care Med 33:847-854, 2005.
41. Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, et al.: Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 351:929-933, 1998.
42. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E: Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334:1697-1702, 1996.
43. Traeey KJ, Vlassara H, Cerami A: Cachectin/tumour necrosis factor. Lancet 1:1122-1126, 1989.
44. Oberholzer A, Keel M, Zellweger R, Steckholzer U, Trerttz O, Ertel W: Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma 48:932-937, 2000.
45. Diodato MD, Knoferl MW, Schwacha MG, Bland KI, Chaudry IH: Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine 14:162-169, 2001.
46. Shimozawa N, Okajima K, Harada N, Arai M, Ishida Y, Shimada S, Kurihara H, Nakagata N: Contribution of sensory neurons to sex difference in the development of stress-induced gastric mucosal injury in mice. Gastroenterology 131:1826-1834, 2006.
47. Montgomery AB, Stager MA, Carrico CJ, Hudson LD: Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 132:485-489, 1985.
48. Estenssoro E, Dubin A, Laffaire E, Canales H, Saenz G, Moseinco M, Pozo M, Gomez A, Baredes N, Jannello G, et al.: Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit Care Med 30:2450-2456, 2002.
49. Zeiher BG, Artigas A, Vincent JL, Dmitrienko A, Jackson K, Thompson BT, Bernard G: Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 32:1695-1702, 2004.
50. Tamakuma S, Ogawa M, Aikawa N, Kubota T, Hirasawa H, Ishizaka A, Taenaka N, Hamada C, Matsuoka S, Abiru T: Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther 17:271-279, 2004.